ADA / EASD 2026 Algorithm · SaMD Platform
Titria is the world's first doctor-supervised, AI-guided basal insulin titration app. Built on the latest clinical guidelines, designed for real patients — people like you.
Presented at DTechCon 2026 · Grand Hyatt Mumbai · Oral Presentation · 10 May 2026
·Built on ADA / EASD 2026 International Clinical Guidelines
·Patent pending · MetaHealth360°C
No spreadsheets. No guesswork. Just 10 seconds and a precise recommendation backed by your doctor.
Every morning, before eating. Use your glucometer — takes 5 seconds. That one number tells Titria everything it needs.
Open Titria, type your reading. The algorithm analyses it against your insulin type, history, and doctor-set target.
Get a precise basal insulin dose recommendation — supervised by your doctor, backed by ADA/EASD 2026 guidelines.
No more calling the clinic. No more guessing. Titria tells you exactly how much insulin to take tonight — and your doctor has already seen your reading.
Get Started FreeTitria is a medical device — not a wellness app. Every recommendation is protected by real clinical safety rules that fire on your individual readings, not just averages.
FBG below 54 mg/dL? Dose reduced, calculator locked, SMS sent to your emergency contact — automatically.
Critical readings go directly to Dr. Raskar. You are never managing this alone.
If your blood sugar drops more than 100 mg/dL over 3 days — even inside safe range — dose is reduced.
Renal disease, age under 18, nocturnal symptoms — algorithm blocks automatically. No exceptions.
Hypoglycemic events in 3-week clinical pilot
Patients reached blood sugar target in pilot cohort
Built on the latest international diabetes management guidelines
Ask anything about your dose, your readings, or your insulin. Titria AI answers based on your actual data — not generic advice from the internet.
Titria's algorithm accounts for the unique pharmacokinetics of your specific insulin — Glargine, Toujeo, or Degludec. This is what makes it different from any calculator you've tried.
Long-acting insulins like Degludec and Toujeo take 6 days to reach steady state. Titria holds dose changes during this window — preventing dangerous stacking. Patent pending.
Once you reach your target blood sugar range, Titria permanently switches to a conservative algorithm. It never goes back to aggressive titration. Unique to Titria.
Patients over 65 with dependent care needs get a conservative algorithm, tighter targets, and a caregiver-assisted consent workflow. ADA 2026 compliant.
DTechCon 2026 — "App-Guided Basal Insulin Titration Using ADA/EASD 2026 Algorithm: A 3-Week Pilot Study" · Grand Hyatt Mumbai · 10 May 2026
Titria doesn't replace clinical judgement — it executes it precisely. The doctor platform gives you full visibility and override at every step of titration.
Every patient, every reading, every safety flag — in one view.
Set any patient's dose directly. Your instruction overrides the algorithm.
Critical readings push to your device immediately. FBG <54, >300, nocturnal symptoms.
Generate full titration reports — printable, for medical records.
Available on Android. iOS coming soon. Doctor supervision included from day one.
Made with ❤️ by Dr. Vivek Raskar, Founder — MetaHealth360°C
Scan to download APK